| Pulse Biosciences, Inc Common Stock (DE) | $3.4b | $53.28 | +0.6% | 389.4K | |
| Arbutus Biopharma Corporation Common Stock | $0.9b | $4.21 | -0.2% | 79.3K | |
| Rani Therapeutics Holdings, Inc. Class A Common Stock | $93.6m | $0.60 | +3.2% | 283.1K | |
| Zentek Ltd. Common Stock | $85.3m | $0.49 | 0.0% | N/A | |
| Clene Inc. Common Stock | $58.0m | $3.94 | 0.0% | 19.6K | |
| NanoViricides Inc. | $32.7m | $1.40 | +0.7% | 157.5K | |
| TransCode Therapeutics, Inc. Common Stock | $26.6m | $1.75 | +3.2% | 31.8K | |
| Polyrizon Ltd. Ordinary Shares | $23.3m | $8.74 | +3.2% | 14.1K | |
| Aspire-Lakewood Holdings, Inc. Common Stock | $12.3m | $8.87 | -1.0% | 14.4K | |
| Lexaria Bioscience Corp. Common Stock | $6.1m | $3.10 | -2.5% | 1.6K |